ID810B - KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYA - Google Patents

KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYA

Info

Publication number
ID810B
ID810B IDP16787A ID870167A ID810B ID 810 B ID810 B ID 810B ID P16787 A IDP16787 A ID P16787A ID 870167 A ID870167 A ID 870167A ID 810 B ID810 B ID 810B
Authority
ID
Indonesia
Prior art keywords
hydroxloride
dimetocysiquinazoline
furoil
anhydrates
piperazin
Prior art date
Application number
IDP16787A
Other languages
English (en)
Inventor
Helmut Dr Schickaneder
Ingomar Dr Grafe
Kurt Henning Dr Ahrens
Original Assignee
Heumann Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Pharma Gmbh & Co filed Critical Heumann Pharma Gmbh & Co
Publication of ID810B publication Critical patent/ID810B/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP16787A 1986-03-21 1987-02-19 KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYA ID810B (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP86103925A EP0237608B1 (de) 1986-03-21 1986-03-21 Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ID810B true ID810B (id) 1996-07-15

Family

ID=8194990

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP16787A ID810B (id) 1986-03-21 1987-02-19 KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYA

Country Status (19)

Country Link
US (1) US4816455B1 (id)
EP (1) EP0237608B1 (id)
JP (1) JPH0662615B2 (id)
KR (1) KR870008875A (id)
AR (1) AR242384A1 (id)
AT (1) ATE72244T1 (id)
AU (1) AU586318B2 (id)
CA (1) CA1240999A (id)
DE (1) DE3683760D1 (id)
DK (1) DK173283B1 (id)
ES (1) ES2009486A6 (id)
GR (1) GR870429B (id)
HU (1) HU200176B (id)
ID (1) ID810B (id)
IE (1) IE59913B1 (id)
IL (1) IL81841A (id)
NZ (1) NZ219644A (id)
PT (1) PT84496B (id)
ZA (1) ZA87966B (id)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5412095A (en) * 1993-04-29 1995-05-02 Abbott Laboratories Terazosin monohydrochloride and processes and intermediate for its production
US5504207A (en) * 1994-10-18 1996-04-02 Abbott Laboratories Process and intermediate for the preparation of terazosin hydrochloride dihydrate
AU3578595A (en) * 1994-11-25 1996-06-19 Nippon Chemiphar Co. Ltd. Quinazoline derivative
US5587377A (en) * 1995-10-24 1996-12-24 Invamed, Inc. Terazosin crystalline polymorph and pharmaceutical compositions thereof
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
DE59611417D1 (de) * 1996-12-20 2007-03-29 Heumann Pharma Gmbh & Co Neue polymorphe Form von Doxazosinmesylat (Form III)
EP1956014B1 (en) 1998-06-19 2019-01-16 Teijin Pharma Limited Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
CL2004001034A1 (es) 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
WO2006052026A1 (ja) * 2004-11-12 2006-05-18 Teijin Pharma Limited ベンズイミダゾール誘導体の酸性塩及びその結晶
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
AU2007247190A1 (en) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh Polymorphs
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
JP5769966B2 (ja) * 2007-08-17 2015-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｆａｂ関連疾患治療用プリン誘導体
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
EA031225B1 (ru) * 2008-08-15 2018-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Ингибиторы дпп-4 для заживления ран
KR20110067096A (ko) 2008-09-10 2011-06-21 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 및 관련 상태를 치료하기 위한 병용 요법
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
TWI508965B (zh) 2008-12-23 2015-11-21 Boehringer Ingelheim Int 有機化合物的鹽形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
NZ602921A (en) 2010-05-05 2016-01-29 Boehringer Ingelheim Int Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
KR20220025926A (ko) 2010-06-24 2022-03-03 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CA2841552C (en) 2011-07-15 2020-06-23 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP2849754B1 (en) 2012-05-14 2022-09-14 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
EP0146642B1 (de) * 1983-11-22 1988-01-20 LUDWIG HEUMANN & CO GMBH Verfahren zur Herstellung von 4-Amino-6,7-dimethoxy-2-(4-(furo-2-yl)-piperazin-1-yl)-chinazolin und dessen physiologisch annehmbarer Salze
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Also Published As

Publication number Publication date
IE59913B1 (en) 1994-04-20
PT84496A (de) 1987-04-01
KR870008875A (ko) 1987-10-21
US4816455A (en) 1989-03-28
IE870705L (en) 1987-09-21
IL81841A0 (en) 1987-10-20
HUT47101A (en) 1989-01-30
IL81841A (en) 1991-06-10
PT84496B (pt) 1989-11-10
JPH0662615B2 (ja) 1994-08-17
JPS62226980A (ja) 1987-10-05
AR242384A1 (es) 1993-03-31
NZ219644A (en) 1989-04-26
ES2009486A6 (es) 1989-10-01
DK173283B1 (da) 2000-06-13
EP0237608A1 (de) 1987-09-23
ATE72244T1 (de) 1992-02-15
ZA87966B (en) 1987-08-04
CA1240999A (en) 1988-08-23
AU586318B2 (en) 1989-07-06
EP0237608B1 (de) 1992-01-29
DK139887A (da) 1987-09-22
US4816455B1 (en) 1992-11-24
DK139887D0 (da) 1987-03-18
AU6870787A (en) 1987-09-24
HU200176B (en) 1990-04-28
GR870429B (en) 1987-07-13
DE3683760D1 (de) 1992-03-12

Similar Documents

Publication Publication Date Title
ID810B (id) KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYA
IT1230055B (it) Processo per la produzione di allumine boemitiche.
BR8602447A (pt) Politioeter liquido,processo para sua producao e processo para producao de monomeros dihidroxi
BR8803525A (pt) Composicao,composto e processo para a producao de um composto
BR8901552A (pt) Artigo de ceramica aglomerada;estrutura de ceramica aglomerada;processo para a preparacao de uma estrutura de ceramica aglomerada
IS1546B (is) Aðferð til framleiðslu afoxandi efnis
BR8406993A (pt) Processo para producao de microcapsulas
BR8703345A (pt) Processo para producao de cloro
ES548568A0 (es) Procedimiento para la produccion de material pigmentario.
BR9005487A (pt) Processo para producao de compostos de carbonila ativa
NO904453D0 (no) Fremgangsmaate for fremstilling av bituminoese materialer.
MX3681A (es) Procedimiento para la produccion de gamma-carbolinas antipsicoticas y compuestos obtenidos.
NO875134L (no) Fremgangsmaate ved fremstilling av smoereolje.
BR8702344A (pt) Alcoxi alcoxidos,processo para a fabricacao dos mesmos e composicao
BR8701887A (pt) Corpo refratario ignitado ligado por carbono,processo para producao de corpo refratario e corpo refratario
BR8904168A (pt) Processo para producao de oxido de titanio
BR8702800A (pt) Processo para fabricacao de acendedor,acendedor e pluraridade de acendedores
FI872930A7 (fi) Analogiamenetelmä ripulinvastaisten 4-(bentsoyyliamino)piperidiinibutaaniamidijohdannaisten valmistamiseksi
BR8804414A (pt) Processo para a producao de dos 2,2,4-monoesteres tri-substitui-insaturados
BR8900171A (pt) Processo para producao de catalisador zeolitico
BR8902740A (pt) Processo para a preparacao de 2,2,4-trimetil-1,2-dihidroquinolina oligomera
BR8505449A (pt) Processo para producao de 1,3-dimetil-2-imidazolidinona
BR9006284A (pt) Processo para producao de norcanfano dicarbonitrilas
IT8920522A0 (it) Procedimento per la produzione di vanadio areni.
DK489687A (da) Fremgangsmaade til gaering af stivelsesmateriale